PDGFRA and neoplasm: The platelet-derived growth factor receptor α (PDGFRA), known to be associated with tumor aggressiveness in lymph node-negative breast cancer patients who had not received adjuvant systemic therapy69, after treatment of SAHA or SAHA + TRAIL was significantly upregulated MDA-MB-231 cells.